PAVmedPAVM
About: PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Employees: 107
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
47% more capital invested
Capital invested by funds: $936K [Q2] → $1.38M (+$443K) [Q3]
0.91% less ownership
Funds ownership: 11.67% [Q2] → 10.77% (-0.91%) [Q3]
15% less funds holding
Funds holding: 26 [Q2] → 22 (-4) [Q3]
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Ascendiant Capital Edward Woo 44% 1-year accuracy 26 / 59 met price target | 2,070%upside $21 | Buy Maintained | 10 Sept 2024 |
Financial journalist opinion
Based on 7 articles about PAVM published over the past 30 days